Rebecca Meshaw - Concepedia

Author

Rebecca Meshaw

Also Known As

Rebecca L. Meshaw, Rebecca Meshaw

Publications

153

Citations

H-Index

Concepts

All Affiliations

Rebecca Meshaw is an author at Duke Medical Center specializing in immunology, biomedical engineering, and antibody engineering.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	23
2	Biomedical Engineering	1	1	23
3	Immunology	1	1	23
4	Pharmacology	1	1	14
5	Antibody Engineering	1	1	23

Rebecca Meshaw

Publications

138

Citations

H-Index

Page 1

	Year	Citations
Evaluation of an 131I-labeled HER2-specific single domain antibody fragment for the radiopharmaceutical therapy of HER2-expressing cancers Yutian Feng, Rebecca Meshaw, Darryl McDougald, Scientific Reports	2022	30
Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose<sup>211</sup>At-Labeled Anti-HER2 Single-Domain Antibody Fragment Yutian Feng, Rebecca Meshaw, Xiaoguang Zhao, Journal of Nuclear Medicine	2022	29
Site-specific radioiodination of an anti-HER2 single domain antibody fragment with a residualizing prosthetic agent Yutian Feng, Zhengyuan Zhou, Darryl McDougald, Nuclear Medicine and Biology Site-specific RadioiodinationImmunocytochemical TechniqueImmunologyAntibody EngineeringBiomedical Engineering	2020	23
Site-Specific and Residualizing Linker for <sup>18</sup>F Labeling with Enhanced Renal Clearance: Application to an Anti-HER2 Single-Domain Antibody Fragment Zhengyuan Zhou, Rebecca Meshaw, Michael R. Zalutsky, Journal of Nuclear Medicine	2021	23
Site-Specific Radiohalogenation of a HER2-Targeted Single-Domain Antibody Fragment Using a Novel Residualizing Prosthetic Agent Yutian Feng, Samantha M. Sarrett, Rebecca Meshaw, Journal of Medicinal Chemistry	2022	19
A third generation PSMA-targeted agent [211At]YF2: Synthesis and in vivo evaluation Yutian Feng, Rebecca Meshaw, S. W. Finch, Nuclear Medicine and Biology PharmacologyRadiation OncologyVivo Evaluation	2024	14

Page 1